| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.92e-07 | 188 | 66 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZSCAN29 HOXA13 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF726P1 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 NOTCH2 | 2.73e-06 | 1271 | 66 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 FBN1 CELSR3 NRXN1 LRP1 LTBP1 LTBP2 PRKCSH DLL1 FBN3 NOTCH2 LRP8 | 5.44e-06 | 749 | 66 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZSCAN29 HOXA13 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF726P1 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 1.00e-05 | 1244 | 66 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZSCAN29 HOXA13 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF726P1 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 NOTCH2 | 1.05e-05 | 1412 | 66 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.87e-05 | 16 | 66 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.40e-05 | 21 | 66 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZSCAN29 HOXA13 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF726P1 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 6.47e-05 | 1459 | 66 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | scavenger receptor activity | 9.53e-05 | 27 | 66 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | microfibril binding | 1.60e-04 | 6 | 66 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.80e-04 | 85 | 66 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.97e-03 | 20 | 66 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.54e-03 | 891 | 66 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | integrin binding | 2.69e-03 | 175 | 66 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | Notch binding | 3.58e-03 | 27 | 66 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 3.85e-05 | 199 | 65 | 6 | GO:0051147 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 5.47e-05 | 212 | 65 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 5.84e-05 | 4 | 65 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 6.49e-05 | 134 | 65 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | endothelial cell fate specification | 9.72e-05 | 5 | 65 | 2 | GO:0060847 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CELSR3 NRXN1 UBE3A LRP1 LAMA2 LAMB1 ADAM10 TCTN1 NOTCH2 LRP8 | 1.09e-04 | 748 | 65 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | heart development | 1.20e-04 | 757 | 65 | 10 | GO:0007507 | |
| GeneOntologyBiologicalProcess | circulatory system development | HOXA13 STAB2 FBN1 SALL1 NRXN1 WNT2 WIF1 LRP1 LAMA4 LTBP1 DLL1 ZNF418 ADAM10 NOTCH2 | 1.30e-04 | 1442 | 65 | 14 | GO:0072359 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CELSR3 NRXN1 UBE3A LRP1 LAMA2 LAMB1 ADAM10 TCTN1 NOTCH2 LRP8 | 1.93e-04 | 802 | 65 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | vasculature development | HOXA13 STAB2 NRXN1 WNT2 WIF1 LRP1 LAMA4 LTBP1 DLL1 ADAM10 NOTCH2 | 2.03e-04 | 969 | 65 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 2.10e-04 | 516 | 65 | 8 | GO:0016055 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CELSR3 NRXN1 UBE3A LRP1 LAMA2 LAMB1 ADAM10 TCTN1 NOTCH2 LRP8 | 2.28e-04 | 819 | 65 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CELSR3 NRXN1 UBE3A LRP1 LAMA2 LAMB1 ADAM10 TCTN1 NOTCH2 LRP8 | 2.44e-04 | 826 | 65 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 2.70e-04 | 99 | 65 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 2.70e-04 | 8 | 65 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.75e-04 | 285 | 65 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.81e-04 | 286 | 65 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 3.07e-04 | 850 | 65 | 10 | GO:0071363 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.10e-04 | 412 | 65 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HOXA13 CELSR3 NRXN1 UBE3A ADAM7 LRP1 LAMA2 LAMB1 ADAM10 TCTN1 NOTCH2 LRP8 | 3.11e-04 | 1194 | 65 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | endothelial cell fate commitment | 3.47e-04 | 9 | 65 | 2 | GO:0060839 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 3.74e-04 | 195 | 65 | 5 | GO:0030178 | |
| GeneOntologyBiologicalProcess | response to growth factor | 4.15e-04 | 883 | 65 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | gliogenesis | 4.29e-04 | 435 | 65 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 4.33e-04 | 10 | 65 | 2 | GO:0002315 | |
| GeneOntologyBiologicalProcess | proximal tubule development | 4.33e-04 | 10 | 65 | 2 | GO:0072014 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.91e-04 | 445 | 65 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 5.28e-04 | 11 | 65 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 5.28e-04 | 11 | 65 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | neuron development | CELSR3 NRXN1 UBE3A OTOGL LRP1 LAMA2 LAMB1 PRKCSH LGI4 ADAM10 TCTN1 NOTCH2 LRP8 | 5.55e-04 | 1463 | 65 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | CELSR3 NRXN1 UBE3A OTOGL LRP1 LAMA2 LAMB1 PRKCSH ADAM10 TCTN1 NOTCH2 LRP8 | 6.03e-04 | 1285 | 65 | 12 | GO:0031175 |
| GeneOntologyBiologicalProcess | blood vessel development | 6.17e-04 | 929 | 65 | 10 | GO:0001568 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 7.46e-04 | 13 | 65 | 2 | GO:2001204 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 7.46e-04 | 13 | 65 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 7.46e-04 | 13 | 65 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.87e-04 | 482 | 65 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | SALL1 RANBP3L WNT2 ADAM7 WIF1 LRP1 LAMA2 LRP3 LAMB1 NOTCH2 LRP8 | 8.07e-04 | 1141 | 65 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 8.68e-04 | 14 | 65 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 8.68e-04 | 14 | 65 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 1.05e-03 | 368 | 65 | 6 | GO:0030111 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 1.08e-03 | 64 | 65 | 3 | GO:0061001 | |
| GeneOntologyCellularComponent | extracellular matrix | FBN1 VWF OTOGL WNT2 LAMA2 LAMA4 ADAMTS18 LAMB1 PLAT LTBP1 LTBP2 ADAM10 USH2A FBN3 | 1.34e-08 | 656 | 66 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBN1 VWF OTOGL WNT2 LAMA2 LAMA4 ADAMTS18 LAMB1 PLAT LTBP1 LTBP2 ADAM10 USH2A FBN3 | 1.39e-08 | 658 | 66 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FBN1 VWF WNT2 LAMA2 LAMA4 LAMB1 PLAT LTBP1 LTBP2 ADAM10 USH2A | 7.64e-07 | 530 | 66 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 8.41e-06 | 13 | 66 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 4.19e-05 | 122 | 66 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | STAB2 VWF NRXN1 LMO7 WIF1 LRP1 CORIN PLAT ADAM10 NOTCH2 LRP8 | 6.62e-04 | 1111 | 66 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 7.49e-04 | 13 | 66 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 8.61e-04 | 59 | 66 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.29e-03 | 17 | 66 | 2 | GO:0098637 | |
| Domain | EGF_1 | STAB2 FBN1 CELSR3 NRXN1 WIF1 LRP1 LAMA2 LAMA4 LAMB1 PLAT LTBP1 LTBP2 DLL1 USH2A FBN3 MEGF10 NOTCH2 LRP8 | 3.06e-19 | 255 | 64 | 18 | PS00022 |
| Domain | EGF | STAB2 FBN1 CELSR3 NRXN1 WIF1 LRP1 LAMA2 LAMA4 LAMB1 PLAT LTBP1 LTBP2 DLL1 FBN3 MEGF10 NOTCH2 LRP8 | 2.26e-18 | 235 | 64 | 17 | SM00181 |
| Domain | EGF-like_dom | STAB2 FBN1 CELSR3 NRXN1 WIF1 LRP1 LAMA2 LAMA4 LAMB1 PLAT LTBP1 LTBP2 DLL1 FBN3 MEGF10 NOTCH2 LRP8 | 6.06e-18 | 249 | 64 | 17 | IPR000742 |
| Domain | EGF-like_CS | STAB2 FBN1 CELSR3 NRXN1 WIF1 LRP1 LAMA2 LAMA4 LAMB1 PLAT LTBP1 LTBP2 DLL1 FBN3 MEGF10 NOTCH2 LRP8 | 1.34e-17 | 261 | 64 | 17 | IPR013032 |
| Domain | EGF_2 | STAB2 FBN1 CELSR3 NRXN1 WIF1 LRP1 LAMA2 LAMB1 PLAT LTBP1 LTBP2 DLL1 FBN3 MEGF10 NOTCH2 LRP8 | 4.56e-16 | 265 | 64 | 16 | PS01186 |
| Domain | EGF | STAB2 CELSR3 NRXN1 WIF1 LRP1 PLAT LTBP1 LTBP2 DLL1 FBN3 NOTCH2 LRP8 | 1.27e-14 | 126 | 64 | 12 | PF00008 |
| Domain | EGF_3 | STAB2 FBN1 CELSR3 NRXN1 WIF1 LRP1 PLAT LTBP1 LTBP2 DLL1 FBN3 MEGF10 NOTCH2 LRP8 | 4.63e-14 | 235 | 64 | 14 | PS50026 |
| Domain | ASX_HYDROXYL | 1.46e-12 | 100 | 64 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.64e-12 | 106 | 64 | 10 | IPR000152 | |
| Domain | EGF_CA | 1.09e-11 | 122 | 64 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.29e-11 | 124 | 64 | 10 | IPR001881 | |
| Domain | EGF_Lam | 2.47e-11 | 35 | 64 | 7 | SM00180 | |
| Domain | Laminin_EGF | 4.59e-11 | 38 | 64 | 7 | IPR002049 | |
| Domain | Growth_fac_rcpt_ | 1.27e-10 | 156 | 64 | 10 | IPR009030 | |
| Domain | EGF_LAM_2 | 7.09e-10 | 30 | 64 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 7.09e-10 | 30 | 64 | 6 | PS01248 | |
| Domain | EGF_Ca-bd_CS | 1.38e-09 | 97 | 64 | 8 | IPR018097 | |
| Domain | EGF_CA | 1.62e-09 | 99 | 64 | 8 | PS01187 | |
| Domain | Laminin_EGF | 1.91e-09 | 35 | 64 | 6 | PF00053 | |
| Domain | TB | 4.35e-09 | 7 | 64 | 4 | PF00683 | |
| Domain | - | 8.69e-09 | 8 | 64 | 4 | 3.90.290.10 | |
| Domain | TB | 1.56e-08 | 9 | 64 | 4 | PS51364 | |
| Domain | TB_dom | 1.56e-08 | 9 | 64 | 4 | IPR017878 | |
| Domain | EGF_CA | 1.72e-08 | 86 | 64 | 7 | PF07645 | |
| Domain | hEGF | 3.73e-08 | 28 | 64 | 5 | PF12661 | |
| Domain | - | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 5.48e-08 | 679 | 64 | 14 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 7.18e-08 | 694 | 64 | 14 | IPR013087 |
| Domain | LAM_G_DOMAIN | 1.85e-07 | 38 | 64 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 2.42e-07 | 40 | 64 | 5 | PF02210 | |
| Domain | ZINC_FINGER_C2H2_2 | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 2.77e-07 | 775 | 64 | 14 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 2.86e-07 | 777 | 64 | 14 | PS00028 |
| Domain | KRAB | ZNF132 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 3.57e-07 | 358 | 64 | 10 | PS50805 |
| Domain | KRAB | ZNF132 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 3.57e-07 | 358 | 64 | 10 | PF01352 |
| Domain | Groucho_enhance | 3.82e-07 | 5 | 64 | 3 | IPR009146 | |
| Domain | TLE_N | 3.82e-07 | 5 | 64 | 3 | PF03920 | |
| Domain | Groucho/TLE_N | 3.82e-07 | 5 | 64 | 3 | IPR005617 | |
| Domain | Znf_C2H2-like | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 3.83e-07 | 796 | 64 | 14 | IPR015880 |
| Domain | LamG | 3.95e-07 | 44 | 64 | 5 | SM00282 | |
| Domain | Znf_C2H2 | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 4.39e-07 | 805 | 64 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 ZNF654 | 4.59e-07 | 808 | 64 | 14 | SM00355 |
| Domain | KRAB | ZNF132 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 4.71e-07 | 369 | 64 | 10 | SM00349 |
| Domain | KRAB | ZNF132 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 4.82e-07 | 370 | 64 | 10 | IPR001909 |
| Domain | - | 4.96e-07 | 46 | 64 | 5 | 4.10.400.10 | |
| Domain | zf-C2H2 | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 5.18e-07 | 693 | 64 | 13 | PF00096 |
| Domain | LDrepeatLR_classA_rpt | 6.84e-07 | 49 | 64 | 5 | IPR002172 | |
| Domain | LDLa | 6.84e-07 | 49 | 64 | 5 | SM00192 | |
| Domain | Laminin_G | 1.61e-06 | 58 | 64 | 5 | IPR001791 | |
| Domain | cEGF | 1.77e-06 | 26 | 64 | 4 | IPR026823 | |
| Domain | cEGF | 1.77e-06 | 26 | 64 | 4 | PF12662 | |
| Domain | LDLR_class-A_CS | 1.04e-05 | 40 | 64 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 1.68e-05 | 45 | 64 | 4 | PF00057 | |
| Domain | - | 1.84e-05 | 95 | 64 | 5 | 2.60.120.200 | |
| Domain | Laminin_N | 2.08e-05 | 16 | 64 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 2.08e-05 | 16 | 64 | 3 | PS51117 | |
| Domain | Laminin_N | 2.08e-05 | 16 | 64 | 3 | PF00055 | |
| Domain | LamNT | 2.08e-05 | 16 | 64 | 3 | SM00136 | |
| Domain | LDLRA_1 | 2.18e-05 | 48 | 64 | 4 | PS01209 | |
| Domain | LDLRA_2 | 2.37e-05 | 49 | 64 | 4 | PS50068 | |
| Domain | FBN | 3.46e-05 | 3 | 64 | 2 | IPR011398 | |
| Domain | EGF_extracell | 5.29e-05 | 60 | 64 | 4 | IPR013111 | |
| Domain | EGF_2 | 5.29e-05 | 60 | 64 | 4 | PF07974 | |
| Domain | Prefoldin | 1.08e-04 | 72 | 64 | 4 | IPR009053 | |
| Domain | Laminin_aI | 1.15e-04 | 5 | 64 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.15e-04 | 5 | 64 | 2 | PF06008 | |
| Domain | Laminin_II | 1.15e-04 | 5 | 64 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.15e-04 | 5 | 64 | 2 | IPR010307 | |
| Domain | Peptidase_M12B_N | 3.21e-04 | 39 | 64 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.21e-04 | 39 | 64 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.46e-04 | 40 | 64 | 3 | PS00427 | |
| Domain | Reprolysin | 3.46e-04 | 40 | 64 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 3.46e-04 | 40 | 64 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.46e-04 | 40 | 64 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.46e-04 | 40 | 64 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 3.73e-04 | 41 | 64 | 3 | IPR001762 | |
| Domain | ConA-like_dom | 9.20e-04 | 219 | 64 | 5 | IPR013320 | |
| Domain | Ldl_recept_b | 1.02e-03 | 14 | 64 | 2 | PF00058 | |
| Domain | LDLRB | 1.02e-03 | 14 | 64 | 2 | PS51120 | |
| Domain | LY | 1.18e-03 | 15 | 64 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.18e-03 | 15 | 64 | 2 | IPR000033 | |
| Domain | - | 2.11e-03 | 20 | 64 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 2.33e-03 | 21 | 64 | 2 | PF00200 | |
| Domain | DISIN | 2.33e-03 | 21 | 64 | 2 | SM00050 | |
| Domain | MetalloPept_cat_dom | 2.71e-03 | 81 | 64 | 3 | IPR024079 | |
| Domain | - | 2.71e-03 | 81 | 64 | 3 | 3.40.390.10 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBN1 VWF NRXN1 LAMA2 LAMA4 ADAMTS18 LAMB1 LTBP1 LTBP2 ADAM10 FBN3 | 6.03e-09 | 300 | 50 | 11 | M610 |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.68e-06 | 25 | 50 | 4 | M39713 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 4.95e-06 | 10 | 50 | 3 | MM15156 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.13e-06 | 74 | 50 | 5 | M616 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.48e-06 | 37 | 50 | 4 | M27134 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.49e-05 | 14 | 50 | 3 | M27402 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.71e-05 | 44 | 50 | 4 | M26969 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.52e-05 | 59 | 50 | 4 | M27218 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 6.17e-05 | 22 | 50 | 3 | M27210 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 7.50e-05 | 124 | 50 | 5 | M27285 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.58e-05 | 66 | 50 | 4 | M18 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.03e-04 | 26 | 50 | 3 | MM14793 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.16e-04 | 27 | 50 | 3 | M39545 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.33e-04 | 140 | 50 | 5 | M587 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.59e-04 | 30 | 50 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.59e-04 | 30 | 50 | 3 | M27216 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.94e-04 | 32 | 50 | 3 | MM14854 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.94e-04 | 32 | 50 | 3 | MM14975 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 2.13e-04 | 33 | 50 | 3 | M604 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.19e-04 | 84 | 50 | 4 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.22e-04 | 246 | 50 | 6 | M10189 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.56e-04 | 7 | 50 | 2 | M27199 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.87e-04 | 258 | 50 | 6 | MM14572 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.25e-04 | 38 | 50 | 3 | MM14874 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.41e-04 | 8 | 50 | 2 | M47850 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.51e-04 | 39 | 50 | 3 | MM14601 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.07e-04 | 41 | 50 | 3 | M27778 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.37e-04 | 42 | 50 | 3 | M27272 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.69e-04 | 43 | 50 | 3 | M53 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 5.72e-04 | 46 | 50 | 3 | M239 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 5.72e-04 | 46 | 50 | 3 | M48243 | |
| Pathway | PID_PS1_PATHWAY | 5.72e-04 | 46 | 50 | 3 | M70 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.10e-04 | 47 | 50 | 3 | M646 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.49e-04 | 48 | 50 | 3 | M611 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 6.64e-04 | 11 | 50 | 2 | M158 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.95e-04 | 12 | 50 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.95e-04 | 12 | 50 | 2 | M22042 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 8.50e-04 | 120 | 50 | 4 | MM14982 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 9.38e-04 | 13 | 50 | 2 | M47423 | |
| Pathway | PID_NOTCH_PATHWAY | 1.19e-03 | 59 | 50 | 3 | M17 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.26e-03 | 15 | 50 | 2 | M27202 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.62e-03 | 17 | 50 | 2 | M39389 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.03e-03 | 19 | 50 | 2 | MM15594 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.46e-03 | 76 | 50 | 3 | M27219 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.51e-03 | 161 | 50 | 4 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.55e-03 | 77 | 50 | 3 | MM14670 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 2.72e-03 | 22 | 50 | 2 | M39480 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.75e-03 | 79 | 50 | 3 | M27643 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 2.75e-03 | 79 | 50 | 3 | MM14754 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 2.97e-03 | 23 | 50 | 2 | MM15936 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 3.05e-03 | 82 | 50 | 3 | MM15922 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.27e-03 | 84 | 50 | 3 | M3228 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 3.38e-03 | 85 | 50 | 3 | M27079 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.51e-03 | 25 | 50 | 2 | M27879 | |
| Pathway | WNT_SIGNALING | 3.85e-03 | 89 | 50 | 3 | M5493 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.10e-03 | 91 | 50 | 3 | M27101 | |
| Pathway | WP_FOCAL_ADHESION | 4.29e-03 | 187 | 50 | 4 | MM15913 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 4.39e-03 | 28 | 50 | 2 | M77 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 4.39e-03 | 28 | 50 | 2 | M47835 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.49e-03 | 94 | 50 | 3 | M1041 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 4.71e-03 | 29 | 50 | 2 | M29808 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.76e-03 | 96 | 50 | 3 | M39834 | |
| Pathway | WP_FOCAL_ADHESION | 5.35e-03 | 199 | 50 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.35e-03 | 199 | 50 | 4 | M7253 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 5.37e-03 | 31 | 50 | 2 | MM1343 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 5.37e-03 | 31 | 50 | 2 | M592 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 6.07e-03 | 33 | 50 | 2 | M39503 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 6.07e-03 | 33 | 50 | 2 | M6220 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 6.10e-03 | 330 | 50 | 5 | M7847 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 6.94e-03 | 110 | 50 | 3 | MM15977 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.04e-11 | 11 | 67 | 5 | 15499562 | |
| Pubmed | 6.28e-11 | 5 | 67 | 4 | 1303260 | ||
| Pubmed | 6.74e-11 | 15 | 67 | 5 | 9291577 | ||
| Pubmed | 1.22e-09 | 167 | 67 | 8 | 22159717 | ||
| Pubmed | 1.77e-09 | 175 | 67 | 8 | 28071719 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 17293099 | ||
| Pubmed | 1.40e-08 | 146 | 67 | 7 | 27068509 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.71e-08 | 248 | 67 | 8 | 24006456 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 8645603 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 9201115 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 8365415 | ||
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 8573724 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.82e-07 | 26 | 67 | 4 | 34189436 | |
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 2.38e-07 | 7 | 67 | 3 | 24024827 | |
| Pubmed | 2.38e-07 | 7 | 67 | 3 | 14557481 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.51e-07 | 135 | 67 | 6 | 28675934 | |
| Pubmed | 3.80e-07 | 8 | 67 | 3 | 16002402 | ||
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 3.80e-07 | 8 | 67 | 3 | 20735826 | |
| Pubmed | 5.25e-07 | 153 | 67 | 6 | 25037231 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 7.92e-07 | 37 | 67 | 4 | 34323105 | |
| Pubmed | 8.12e-07 | 10 | 67 | 3 | 9034910 | ||
| Pubmed | 8.12e-07 | 10 | 67 | 3 | 30571765 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 8.12e-07 | 10 | 67 | 3 | 18590826 | |
| Pubmed | 8.12e-07 | 10 | 67 | 3 | 11784026 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.12e-06 | 11 | 67 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.12e-06 | 11 | 67 | 3 | 23472759 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.28e-06 | 97 | 67 | 5 | 27559042 | |
| Pubmed | 1.48e-06 | 12 | 67 | 3 | 9396756 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.48e-06 | 12 | 67 | 3 | 11266540 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 36350252 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 22735158 | ||
| Pubmed | 2.45e-06 | 14 | 67 | 3 | 17202186 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | UBE2J1 FBN1 CELSR3 LRP1 LAMA4 LAMB1 LTBP1 LTBP2 PRKCSH ADAM10 NOTCH2 LRP8 | 2.83e-06 | 1201 | 67 | 12 | 35696571 |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.06e-06 | 15 | 67 | 3 | 15895400 | |
| Pubmed | 3.06e-06 | 15 | 67 | 3 | 10625553 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 3.06e-06 | 15 | 67 | 3 | 12921739 | |
| Pubmed | 3.37e-06 | 118 | 67 | 5 | 21078624 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 1502153 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 14660750 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 25858550 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 18321860 | ||
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 3.66e-06 | 2 | 67 | 2 | 12871934 | |
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 3.66e-06 | 2 | 67 | 2 | 28669633 | |
| Pubmed | Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression. | 3.66e-06 | 2 | 67 | 2 | 25446531 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 36801171 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 32977685 | ||
| Pubmed | Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. | 3.66e-06 | 2 | 67 | 2 | 10632583 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 23954203 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 15221638 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 27503326 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 26237273 | ||
| Pubmed | Coordinate control of axon defasciculation and myelination by laminin-2 and -8. | 3.66e-06 | 2 | 67 | 2 | 15699217 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 3.66e-06 | 2 | 67 | 2 | 24484584 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 14729866 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 12445472 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 15905513 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24867584 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 26590955 | ||
| Pubmed | 3.76e-06 | 16 | 67 | 3 | 17601529 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 4.56e-06 | 17 | 67 | 3 | 15056720 | |
| Pubmed | 5.46e-06 | 18 | 67 | 3 | 11311202 | ||
| Pubmed | 5.46e-06 | 18 | 67 | 3 | 33658226 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 5.46e-06 | 18 | 67 | 3 | 39040056 | |
| Pubmed | 5.46e-06 | 18 | 67 | 3 | 11731482 | ||
| Pubmed | 7.61e-06 | 20 | 67 | 3 | 22911573 | ||
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 7.61e-06 | 20 | 67 | 3 | 11859196 | |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 8.87e-06 | 21 | 67 | 3 | 22767514 | |
| Pubmed | 1.03e-05 | 22 | 67 | 3 | 28334989 | ||
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 1.03e-05 | 22 | 67 | 3 | 29449451 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 30279425 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 25670857 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31882770 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10225960 | ||
| Pubmed | Cloning of the mouse laminin alpha 4 cDNA. Expression in a subset of endothelium. | 1.10e-05 | 3 | 67 | 2 | 9219532 | |
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 1.10e-05 | 3 | 67 | 2 | 24251389 | |
| Pubmed | Notch signaling confers antigen-presenting cell functions on mast cells. | 1.10e-05 | 3 | 67 | 2 | 19130928 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19608750 | ||
| Pubmed | Tissue-type plasminogen activator regulates macrophage activation and innate immunity. | 1.10e-05 | 3 | 67 | 2 | 28684538 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 25728415 | ||
| Pubmed | The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity. | 1.10e-05 | 3 | 67 | 2 | 30124466 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 17170123 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 16303771 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 24129569 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 8808280 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19672275 | ||
| Pubmed | The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. | 1.10e-05 | 3 | 67 | 2 | 12794186 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 11823422 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 11992244 | ||
| Pubmed | Conclusion of diagnostic odysseys due to inversions disrupting GLI3 and FBN1. | 1.10e-05 | 3 | 67 | 2 | 36411030 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10364433 | ||
| Pubmed | Increased levels of endothelial haemostatic markers in patients with coronary heart disease. | 1.10e-05 | 3 | 67 | 2 | 11864703 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 12807892 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 15976178 | ||
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 1.10e-05 | 3 | 67 | 2 | 30045946 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10743502 | ||
| Pubmed | 1.11e-05 | 71 | 67 | 4 | 33541421 | ||
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 1.34e-05 | 24 | 67 | 3 | 18778483 | |
| Pubmed | 1.72e-05 | 26 | 67 | 3 | 24742657 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 12429738 | ||
| Pubmed | Heterogeneity of Satellite Cells Implicates DELTA1/NOTCH2 Signaling in Self-Renewal. | 2.19e-05 | 4 | 67 | 2 | 32023464 | |
| Interaction | HLX interactions | 6.01e-06 | 37 | 65 | 4 | int:HLX | |
| Interaction | ZNF709 interactions | 8.95e-06 | 13 | 65 | 3 | int:ZNF709 | |
| Interaction | ZNF324 interactions | 1.45e-05 | 46 | 65 | 4 | int:ZNF324 | |
| Interaction | ZNF708 interactions | 2.52e-05 | 18 | 65 | 3 | int:ZNF708 | |
| Interaction | ZFP41 interactions | 3.42e-05 | 57 | 65 | 4 | int:ZFP41 | |
| Interaction | RIPPLY2 interactions | 3.51e-05 | 20 | 65 | 3 | int:RIPPLY2 | |
| Interaction | LAMA2 interactions | 5.42e-05 | 23 | 65 | 3 | int:LAMA2 | |
| Interaction | ST14 interactions | 5.45e-05 | 207 | 65 | 6 | int:ST14 | |
| Interaction | FBN2 interactions | 5.76e-05 | 65 | 65 | 4 | int:FBN2 | |
| Interaction | NTN5 interactions | 6.18e-05 | 24 | 65 | 3 | int:NTN5 | |
| Cytoband | 19q13.43 | 8.42e-06 | 87 | 67 | 4 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 5.76e-05 | 1192 | 67 | 9 | chr19q13 | |
| Cytoband | 14q24.2 | 6.16e-04 | 25 | 67 | 2 | 14q24.2 | |
| Cytoband | 15q22 | 8.30e-04 | 29 | 67 | 2 | 15q22 | |
| Cytoband | 19q13.11 | 1.99e-03 | 45 | 67 | 2 | 19q13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q24 | 3.18e-03 | 200 | 67 | 3 | chr14q24 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZSCAN29 ZNF132 ZNF22 SALL1 ZNF33A ZNF544 ZNF283 ZNF470 ZNF350 ZNF543 ZNF679 ZNF418 ZNF709 | 2.93e-08 | 718 | 48 | 13 | 28 |
| GeneFamily | Laminin subunits | 3.80e-06 | 12 | 48 | 3 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 4.93e-06 | 13 | 48 | 3 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 4.13e-05 | 4 | 48 | 2 | 628 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.32e-03 | 27 | 48 | 2 | 47 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.32e-03 | 27 | 48 | 2 | 1253 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.37e-11 | 196 | 66 | 10 | M3008 | |
| Coexpression | NABA_MATRISOME | FBN1 VWF WNT2 ADAM7 WIF1 LAMA2 LAMA4 ADAMTS18 LAMB1 PLAT LTBP1 LTBP2 LGI4 ADAM10 USH2A FBN3 MEGF10 | 4.30e-10 | 1026 | 66 | 17 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.24e-09 | 191 | 66 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 1.73e-09 | 275 | 66 | 10 | M5884 | |
| Coexpression | NABA_MATRISOME | FBN1 VWF OTOGL WNT2 ADAM7 WIF1 LAMA2 LAMA4 ADAMTS18 LAMB1 PLAT LTBP1 LTBP2 LGI4 ADAM10 MEGF10 | 2.86e-09 | 1008 | 66 | 16 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 2.53e-08 | 270 | 66 | 9 | MM17057 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.81e-06 | 35 | 66 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.03e-06 | 36 | 66 | 4 | MM1212 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.13e-06 | 40 | 66 | 4 | M5887 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.05e-05 | 54 | 66 | 4 | M4737 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 1.14e-05 | 200 | 66 | 6 | M9657 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 3.32e-05 | 359 | 66 | 7 | M15193 | |
| Coexpression | HEVNER_CORTEX_COMMITTED_TO_CORTICOTHALAMIC_PROJECTION_NEURON_FATE | 3.37e-05 | 25 | 66 | 3 | MM424 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 3.87e-05 | 505 | 66 | 8 | M39167 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 5.75e-05 | 163 | 66 | 5 | M12112 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 7.18e-05 | 32 | 66 | 3 | M5903 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 8.70e-05 | 567 | 66 | 8 | M2129 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.02e-04 | 184 | 66 | 5 | M8544 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.13e-04 | 188 | 66 | 5 | MM983 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 1.29e-04 | 600 | 66 | 8 | M39055 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 1.56e-04 | 107 | 66 | 4 | M4913 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.20e-04 | 117 | 66 | 4 | M39300 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.38e-04 | 493 | 66 | 7 | M19391 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 2.91e-04 | 126 | 66 | 4 | M39132 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 3.03e-04 | 681 | 66 | 8 | M39175 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 3.28e-04 | 130 | 66 | 4 | M40147 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.66e-07 | 97 | 66 | 6 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.42e-06 | 377 | 66 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 7.13e-06 | 86 | 66 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 7.15e-06 | 431 | 66 | 9 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 5.79e-05 | 217 | 66 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_100 | 9.23e-05 | 76 | 66 | 4 | gudmap_developingKidney_e12.5_renal vesicle_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.45e-05 | 147 | 66 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | HOXA13 SALL1 LMO7 TLE4 WIF1 LAMA4 ADAMTS18 LTBP1 MEGF10 LRP8 | 1.23e-04 | 769 | 66 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 1.29e-04 | 157 | 66 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_100 | 1.43e-04 | 85 | 66 | 4 | gudmap_developingKidney_e11.5_metaneph mesench_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 1.43e-04 | 783 | 66 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_200 | 1.45e-04 | 161 | 66 | 5 | gudmap_developingKidney_e12.5_renal vesicle_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.48e-04 | 370 | 66 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 1.67e-04 | 166 | 66 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.67e-04 | 166 | 66 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.67e-04 | 166 | 66 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_200 | 1.87e-04 | 170 | 66 | 5 | gudmap_developingKidney_e13.5_podocyte cells_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 2.05e-04 | 390 | 66 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 2.07e-04 | 37 | 66 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.32e-04 | 398 | 66 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#1_top-relative-expression-ranked_200 | 2.63e-04 | 8 | 66 | 2 | gudmap_developingKidney_e11.5_ureteric bud_200_k1 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 2.87e-04 | 291 | 66 | 6 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | STAB2 SALL1 LAMA4 ADAMTS18 CORIN PLAT LTBP1 DLL1 MEGF10 LRP8 | 2.90e-04 | 855 | 66 | 10 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | 2.99e-04 | 415 | 66 | 7 | gudmap_developingKidney_e15.5_Podocyte cells_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 3.05e-04 | 189 | 66 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | 3.40e-04 | 424 | 66 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.61e-04 | 196 | 66 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 4.08e-04 | 437 | 66 | 7 | GSM777046_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 4.14e-04 | 202 | 66 | 5 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 4.19e-04 | 439 | 66 | 7 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.54e-04 | 445 | 66 | 7 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 4.86e-04 | 450 | 66 | 7 | GSM777063_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.01e-04 | 118 | 66 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_200 | 5.68e-04 | 52 | 66 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | KCNMB2 STAB2 FBN1 VWF SALL1 LAMA4 CORIN PLAT LTBP1 PRKCSH SSH2 | 7.36e-04 | 1143 | 66 | 11 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | placenta | 7.48e-04 | 349 | 66 | 6 | placenta | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 8.33e-04 | 806 | 66 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#1_top-relative-expression-ranked_100 | 8.45e-04 | 14 | 66 | 2 | gudmap_developingKidney_e11.5_metaneph mesench_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 9.25e-04 | 818 | 66 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 9.25e-04 | 139 | 66 | 4 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 9.99e-04 | 827 | 66 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 1.04e-03 | 64 | 66 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.09e-03 | 65 | 66 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200 | 1.09e-03 | 65 | 66 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 1.17e-03 | 148 | 66 | 4 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500 | 1.19e-03 | 67 | 66 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 1.21e-03 | 850 | 66 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-10 | 177 | 66 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-10 | 177 | 66 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.86e-10 | 199 | 66 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.10e-10 | 200 | 66 | 8 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-10 | 200 | 66 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 6.10e-10 | 200 | 66 | 8 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-10 | 200 | 66 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-08 | 188 | 66 | 7 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-08 | 189 | 66 | 7 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-08 | 190 | 66 | 7 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-08 | 190 | 66 | 7 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-08 | 191 | 66 | 7 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-08 | 191 | 66 | 7 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-08 | 192 | 66 | 7 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-08 | 192 | 66 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-08 | 192 | 66 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-08 | 192 | 66 | 7 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-08 | 193 | 66 | 7 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.51e-08 | 193 | 66 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-08 | 194 | 66 | 7 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.56e-08 | 194 | 66 | 7 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-08 | 195 | 66 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.62e-08 | 195 | 66 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-08 | 195 | 66 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 196 | 66 | 7 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 196 | 66 | 7 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.68e-08 | 196 | 66 | 7 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-08 | 196 | 66 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 196 | 66 | 7 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-08 | 197 | 66 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.80e-08 | 198 | 66 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-08 | 198 | 66 | 7 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.80e-08 | 198 | 66 | 7 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-08 | 198 | 66 | 7 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-08 | 198 | 66 | 7 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-08 | 198 | 66 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-08 | 199 | 66 | 7 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.86e-08 | 199 | 66 | 7 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-08 | 199 | 66 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-08 | 199 | 66 | 7 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.93e-08 | 200 | 66 | 7 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.93e-08 | 200 | 66 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.93e-08 | 200 | 66 | 7 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-08 | 200 | 66 | 7 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-08 | 200 | 66 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-08 | 200 | 66 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.93e-08 | 200 | 66 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-08 | 200 | 66 | 7 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 1.93e-08 | 200 | 66 | 7 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.93e-08 | 200 | 66 | 7 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-08 | 200 | 66 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-08 | 200 | 66 | 7 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.62e-07 | 164 | 66 | 6 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-07 | 175 | 66 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-07 | 176 | 66 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-07 | 176 | 66 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.90e-07 | 181 | 66 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-07 | 181 | 66 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.00e-07 | 182 | 66 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-07 | 185 | 66 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 185 | 66 | 6 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-07 | 185 | 66 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.40e-07 | 186 | 66 | 6 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-07 | 186 | 66 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.40e-07 | 186 | 66 | 6 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.51e-07 | 187 | 66 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.51e-07 | 187 | 66 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.51e-07 | 187 | 66 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-07 | 188 | 66 | 6 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-07 | 188 | 66 | 6 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-07 | 188 | 66 | 6 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-07 | 188 | 66 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-07 | 189 | 66 | 6 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-07 | 190 | 66 | 6 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-07 | 190 | 66 | 6 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-07 | 190 | 66 | 6 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-07 | 190 | 66 | 6 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-07 | 190 | 66 | 6 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.86e-07 | 190 | 66 | 6 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.86e-07 | 190 | 66 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-07 | 190 | 66 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-07 | 191 | 66 | 6 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.98e-07 | 191 | 66 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.98e-07 | 191 | 66 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-07 | 191 | 66 | 6 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-07 | 191 | 66 | 6 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.98e-07 | 191 | 66 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.10e-07 | 192 | 66 | 6 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 192 | 66 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.10e-07 | 192 | 66 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| Computational | Adhesion molecules. | 1.63e-05 | 141 | 42 | 6 | MODULE_122 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.00e-04 | 384 | 42 | 8 | MODULE_2 | |
| Computational | ECM and collagens. | 2.20e-04 | 225 | 42 | 6 | MODULE_47 | |
| Computational | Ovary genes. | 4.99e-04 | 368 | 42 | 7 | MODULE_1 | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.65e-06 | 197 | 66 | 7 | 5805_DN | |
| Drug | AC1L1G72 | 3.78e-06 | 11 | 66 | 3 | CID000003553 | |
| Disease | Intracranial Thrombosis | 1.34e-05 | 3 | 63 | 2 | C0752143 | |
| Disease | Brain Thrombosis | 1.34e-05 | 3 | 63 | 2 | C0752144 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.34e-05 | 3 | 63 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 1.34e-05 | 3 | 63 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 1.34e-05 | 3 | 63 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 1.34e-05 | 3 | 63 | 2 | C1869114 | |
| Disease | Cerebral Thrombosis | 1.34e-05 | 3 | 63 | 2 | C0079102 | |
| Disease | Brain Thrombus | 1.34e-05 | 3 | 63 | 2 | C0936261 | |
| Disease | Cerebral Thrombus | 1.34e-05 | 3 | 63 | 2 | C0936263 | |
| Disease | Weill-Marchesani syndrome | 2.68e-05 | 4 | 63 | 2 | cv:C0265313 | |
| Disease | von Willebrand's disease 1 (is_implicated_in) | 2.68e-05 | 4 | 63 | 2 | DOID:0060573 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.68e-05 | 4 | 63 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | 8.67e-05 | 1074 | 63 | 10 | C0006142 | |
| Disease | Stage IV Skin Melanoma | 9.36e-05 | 7 | 63 | 2 | C1321872 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.25e-04 | 8 | 63 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | aortic aneurysm | 2.00e-04 | 10 | 63 | 2 | EFO_0001666 | |
| Disease | Autistic Disorder | 2.41e-04 | 261 | 63 | 5 | C0004352 | |
| Disease | Marfan Syndrome | 2.44e-04 | 11 | 63 | 2 | C0024796 | |
| Disease | factor VIII measurement, Ischemic stroke | 7.49e-04 | 19 | 63 | 2 | EFO_0004630, HP_0002140 | |
| Disease | intraocular pressure measurement | 7.57e-04 | 509 | 63 | 6 | EFO_0004695 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 8.32e-04 | 20 | 63 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | myocardial infarction (is_implicated_in) | 1.26e-03 | 99 | 63 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | FEV change measurement, response to zileuton | 1.30e-03 | 25 | 63 | 2 | EFO_0005921, EFO_0007676 | |
| Disease | bone density | 1.44e-03 | 388 | 63 | 5 | EFO_0003923 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 1.52e-03 | 27 | 63 | 2 | EFO_0004629, EFO_0004630 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.88e-03 | 30 | 63 | 2 | EFO_0004629, HP_0002140 | |
| Disease | spontaneous coronary artery dissection | 2.00e-03 | 31 | 63 | 2 | EFO_0010820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQGPCCTAQCAFKSK | 506 | O14672 | |
| LKPGFTCAEGECCES | 436 | Q9H2U9 | |
| TVTKSECCCANPDHG | 636 | Q75N90 | |
| DACGVCKGDNSTCKF | 736 | Q8TE60 | |
| CGCKNDAVCSPVDGS | 456 | Q96KG7 | |
| DAVCSPVDGSCTCKA | 461 | Q96KG7 | |
| DCAFASCTPGSTCID | 341 | Q04721 | |
| ITETFNCSFSCGPDC | 91 | Q9Y691 | |
| CDCKDGSDEPGTAAC | 56 | P14314 | |
| CGDGSDEIPCNKTAC | 2591 | Q07954 | |
| KECCAGPEEKNSCAS | 431 | Q96RV3 | |
| CTCPDGFQLDDNKTC | 1186 | Q14766 | |
| KCSKSCDPGEDCASC | 236 | Q86W56 | |
| FKCVACECDLGGSSS | 1641 | Q8WWI1 | |
| KSCPDGADEKNCFSC | 441 | O75074 | |
| DLSSEDPFGCKSCAC | 446 | P07942 | |
| PCNCNSFGSKSFDCE | 966 | P24043 | |
| GCKACNCSTVGSLDF | 1056 | P24043 | |
| SCDCSMTSFSGPLCN | 1106 | Q9ULB1 | |
| IDYCSSSPCSNGAKC | 406 | O00548 | |
| CKNSPGSFICECSSE | 821 | P35555 | |
| SACCCGSDEDPAASA | 181 | P56746 | |
| PCRSFCEAAKEGCES | 211 | Q9Y5Q5 | |
| GVCTNTAGSFSCKDC | 1106 | Q14767 | |
| GTSAGCPFEKCCSTE | 96 | Q9H2J1 | |
| CDSGPCKNSGFCSER | 1726 | Q9NYQ7 | |
| TACDICGKTFACQSA | 1001 | Q9NSC2 | |
| CPKKTCADSDFTCDN | 81 | Q14114 | |
| LNGAFCSKTGTCDCQ | 86 | Q3ZCN5 | |
| GSTCKKCDCSGNSDP | 181 | Q16363 | |
| CCKFPSSQELEDASC | 186 | Q9Y4I5 | |
| SFCSCVPCEGTADAS | 41 | Q96A25 | |
| CCSAAAGSVGCQVAK | 1016 | Q8N1G1 | |
| NCKACDCDTAGSLPG | 791 | O75445 | |
| EACTCFNCCSKGPTA | 4806 | O75445 | |
| CSCSKDSALCEGSPD | 31 | Q8N135 | |
| GAEAAKQCSPCSAAA | 146 | P31271 | |
| VTPSQCANKGCCFDD | 46 | P04155 | |
| SDSECADNLKCCSAG | 51 | Q14508 | |
| CCSAGCATFCSLPND | 61 | Q14508 | |
| CATFCSLPNDKEGSC | 66 | Q14508 | |
| PFECCDCGKAFSNSS | 486 | P52740 | |
| ACSQGEVKSCSCDPK | 126 | P09544 | |
| EFCSTPACSEGNSDC | 201 | P00750 | |
| NEACTNEFCASCPTF | 46 | Q05086 | |
| AQCSQKPCEDSCRSG | 2466 | P04275 | |
| INGCSSGCCLNESKF | 551 | Q76I76 | |
| SGCCLNESKFPLDNC | 556 | Q76I76 | |
| SPDSKVCFSCCSDGN | 586 | Q04727 | |
| CQPNEDKCSFKSCSS | 196 | Q86VV4 | |
| SYQCEECGKPFNCSS | 211 | Q8IYX0 | |
| CCCDPDCSSVDFSVF | 91 | Q2MV58 | |
| CCFTTASASFPDECE | 86 | Q8IZM8 | |
| AKKSQDFCCEGCGSA | 141 | Q9Y385 | |
| ECIECGKAFSDCSSL | 341 | Q6ECI4 | |
| ACETCADDNLFGPSC | 146 | Q8WWQ8 | |
| CDKANCSTTCFNGGT | 241 | Q9Y5W5 | |
| CKECGKAFDCPSSFQ | 366 | Q8N972 | |
| PDAKVCFSCCSDGNI | 586 | Q04726 | |
| RACGEGFCDSCSSKT | 621 | Q9HBF4 | |
| SFPSRKMFCQCDSCG | 131 | Q06730 | |
| FVCSECGKSCSQKSG | 346 | Q9GZX5 | |
| ECSECGKSFPQSCSL | 511 | Q8TF45 | |
| PFECNECGKAFCESA | 366 | Q08ER8 | |
| EKPSVCNQCGKSFSC | 351 | Q6NX49 | |
| PYQCSECGKCFSQSS | 166 | P17026 | |
| CGECGKCFNQSSSLI | 736 | Q8IWY8 | |
| SFFCDCGAKEDGSCL | 1711 | Q5T4S7 | |
| SGASSPCANTTFCCK | 121 | Q6DKI7 | |
| SPDAKVCFSCCSDGN | 556 | Q04725 | |
| CEECGKAFCQPSTLT | 76 | Q15940 | |
| ECKECGKAFNCGSSL | 516 | Q8N7M2 | |
| FEQCVCTSCGATSDP | 161 | Q70EL1 |